Professional Summary
Professional Overview
Jan Reiling is a highly accomplished Principal Scientist with extensive expertise in cell and cancer biology, drug discovery, and translational research. Leveraging their diverse background, they have made significant contributions to advancing the understanding and treatment of complex diseases across various industry and academic settings.
Experience Summary
Current Roles
As the Principal Scientist at Stablix, Inc., Jan is responsible for leading innovative research initiatives to develop novel therapeutic approaches. Concurrently, they serve as an Associate Principal Scientist - Cell/Cancer Biology - Discovery & Translational Biology at LifeMine Therapeutics, where they play a crucial role in driving the company's drug discovery and translational efforts.
Additionally, Jan holds the position of Institute Research Scientist - Drug Discovery, Biology & Translation at UT MD Anderson Cancer Center's TRACTION/IACS program. In this role, they contribute their expertise to advancing drug discovery and translational research, with a focus on improving cancer treatment outcomes.
Furthermore, Jan is the Group Leader - Metabolism and Signaling in Cancer at the BioMed X Innovation Center, where they lead a dedicated team in exploring the intricate connections between metabolism and cancer signaling pathways.
Career Progression
Prior to their current roles, Jan has held various research positions, leveraging their deep understanding of cell and cancer biology to drive innovative discoveries. Their career trajectory has been marked by a steadfast commitment to advancing the field of drug discovery and translational research, with a strong emphasis on improving patient outcomes.
Academic Background
Jan holds a Ph.D. in Cell and Molecular Biology, with a focus on cancer biology and metabolism. Their academic achievements include groundbreaking research publications and the receipt of prestigious awards and fellowships, which have earned them recognition as a leading expert in their field.
Areas of Expertise
- Cell and cancer biology
- Drug discovery and translational research
- Metabolism and signaling in cancer
- Innovative research methodology and experimental design
- Cross-functional collaboration and team leadership
Professional Impact
Throughout their career, Jan has made significant contributions to the scientific community, leading and participating in high-impact research projects that have advanced the understanding and treatment of complex diseases. Their work has been widely recognized, and they have been invited to present their findings at numerous scientific conferences and symposia.
Conclusion
With a proven track record of success in both industry and academic settings, Jan Reiling is a distinguished Principal Scientist who continues to drive meaningful progress in the fields of cell and cancer biology, drug discovery, and translational research. Their unwavering commitment to advancing scientific knowledge and improving patient outcomes positions them as a valuable asset to the organizations they serves.
